Using anticoagulation or aspirin to prevent stroke. Research was methodologically flawed.
作者信息
Ellis S J, Hans R
出版信息
BMJ. 2000 Apr 8;320(7240):1008-9; author reply 1010-1. doi: 10.1136/bmj.320.7240.1008.
Abstract
摘要
相似文献
1
Using anticoagulation or aspirin to prevent stroke. Research was methodologically flawed.使用抗凝剂或阿司匹林预防中风。研究在方法上存在缺陷。
BMJ. 2000 Apr 8;320(7240):1008-9; author reply 1010-1. doi: 10.1136/bmj.320.7240.1008.
2
3
4
Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?华法林-阿司匹林复发性卒中研究（WARSS）试验：对于预防复发性非心源性缺血性卒中，华法林真的是阿司匹林合理的治疗替代药物吗？
Stroke. 2002 Jun;33(6):1723-6. doi: 10.1161/01.str.0000016922.22707.27.
5
Ximelagatran or warfarin in atrial fibrillation?希美加群与华法林用于治疗房颤？
Lancet. 2004 Feb 28;363(9410):735-6; author reply 736. doi: 10.1016/S0140-6736(04)15678-X.
6
Long term anticoagulation or antiplatelet treatment. How do we decide between warfarin and aspirin?
BMJ. 2001 Jul 28;323(7306):235-6.
7
Using aspirin to prevent stroke.使用阿司匹林预防中风。
JAAPA. 2005 Jun;18(6):55. doi: 10.1097/01720610-200506000-00007.
8
Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.
Expert Rev Cardiovasc Ther. 2012 Apr;10(4):433-9. doi: 10.1586/erc.12.19.
9
Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?抗凝剂、阿司匹林和双嘧达莫用于脑缺血二级预防：哪种对哪种患者最适用？
Cerebrovasc Dis. 2007;24 Suppl 1:107-11. doi: 10.1159/000107385. Epub 2007 Nov 1.
10
Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
Curr Atheroscler Rep. 2002 Jul;4(4):319-25. doi: 10.1007/s11883-002-0011-9.
引用本文的文献
1
Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.长期抗凝或抗血小板治疗。仅华法林已被证明可降低房颤患者的中风风险。
BMJ. 2001 Jul 28;323(7306):233; author reply 235-6.
2
Care is required with cost effectiveness approach.采用成本效益方法时需要谨慎。
BMJ. 2000 Aug 12;321(7258):449.
本文引用的文献
1
Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention.心房颤动与血栓栓塞：卒中预防十年进展
Ann Intern Med. 1999 Nov 2;131(9):688-95. doi: 10.7326/0003-4819-131-9-199911020-00010.
2
Use of antithrombotic measures for stroke prevention in atrial fibrillation.使用抗血栓措施预防心房颤动中的卒中
Heart. 1999 Nov;82(5):570-4. doi: 10.1136/hrt.82.5.570.
3
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.基层医疗中对非风湿性心房颤动患者进行动脉血栓栓塞的一级预防：比较两种强度香豆素与阿司匹林的随机对照试验
BMJ. 1999 Oct 9;319(7215):958-64. doi: 10.1136/bmj.319.7215.958.
4
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.预防心房颤动患者中风的抗栓治疗：一项荟萃分析。
Ann Intern Med. 1999 Oct 5;131(7):492-501. doi: 10.7326/0003-4819-131-7-199910050-00003.
5
Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.心房颤动患者华法林与阿司匹林联合治疗期间的出血情况：AFASAK 2研究。心房颤动、阿司匹林与抗凝治疗。
Arch Intern Med. 1999 Jun 28;159(12):1322-8. doi: 10.1001/archinte.159.12.1322.
6
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Chest. 1998 Nov;114(5 Suppl):579S-589S. doi: 10.1378/chest.114.5_supplement.579s.
7
Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.社区中房颤的患病率及抗凝治疗的适用性
Lancet. 1998 Oct 10;352(9135):1167-71. doi: 10.1016/S0140-6736(98)01401-9.
8
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.固定小剂量华法林预防非风湿性心房颤动患者血栓栓塞及血管性死亡的有效性
Am J Cardiol. 1998 Aug 15;82(4):433-7. doi: 10.1016/s0002-9149(98)00357-9.
9
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.一项全科医疗中房颤的调查：西米德兰兹郡房颤项目
Br J Gen Pract. 1997 May;47(418):285-9.
Zotero 插件